Platelet-rich fibrin and calcium hydroxyapatite (CaHA): the perfect combination to accelerate, potentiate, and extend skin rejuvenation
Keywords:
Radiesse, Platte-rich fibrin, face biostimulation.Abstract
Background: calcium hydroxyapatite (CaHA), classified as a collagen biostimulator, known commercially as Radiesse® (Merz Pharma GmbH & Co. KGaA, Frankfurt, Germany) contains 30% synthetic CaHA suspended in a 70% aqueous sodium carboxymethylcellulose gel matrix. It provides both volume replacement and collagen biostimulation as a primary mechanism of action and has become one of the most effective treatments to rejuvenate the face. However, after the treatment it is necessary to wait for approximately 4 to 6 weeks to achieve any results. Methods: we included 100 patients, all adults and divided into two groups: 50 patients treated with CaHA filler (Radiesse, Merz North America, Inc., Raleigh, NC) in a "traditional dilution" with 0, 5 ml of 2% lidocaine and 2 ml of standard saline solution, so we have 4 ml in total to use 2 ml per side, and 50 patients treated with our new technique with 1.5 ml of CaHA filler diluted with 2.5 ml of Platelet-rich fibrin (PRF) for a total of 4 ml. Results: Platelet-rich fibrin used as a diluent for Radiesse in facial bio stimulation treatments produces superior results in a shorter timeframe, as demonstrated in this case series. Patients experience a unique radiance in their skin during treatment and can expect a safe profile with no severe complications. Conclusion: Using platelet-rich fibrin and Radiesse together is a simple and effective way to boost the product's bio-stimulatory effect. This combination could become a key element in anti-ageing medicine to promote cell regeneration.
References
Jacovella PF. Use of calcium hydroxyapatite (Radiesse) for facial augmentation. Clin Interv Aging. 2008; 3(1):161-74.
Ramphul K, Mejias SG. Is "Snapchat Dysmorphia" a Real Issue? Cureus. 2018; 10(3):e2263.
I believe it is a mental health issue': the rise of Zoom dysmorphia, available online https://www.theguardian.com/ fashion/2021/sep/01/i-believe-its-a-mental-health-issues-rise-of-zoom-dysmorphia (accessed 9th November 2021.
Kanchwala SL, Holloway L, Bucky LP. Reliable soft tissue augmentation. Clinican comparison of injectable soft-tissue fi ller for facial-volumen augmentation. Ann Plast Surg. 2005; 55(1):30–5.
Yutskovskaya YA, Kogan EA. Improved Neocollagenesis and Skin Mechanical Properties After Injection of Diluted Calcium Hydroxylapatite in the Neck and Décolletage: A Pilot Study. J Drugs Dermatol. 2017; 16(1):68-74.
Berlin AL, Hussain M, Goldberg DJ. Calcium hydroxyapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg. 2008; 34 Suppl 1:S64-7.
Jansen DA, Graivier MH. Soft tissue substitutes in perioral augmentation. Sem in Plast Surg. 2003; 17:181–98.
Idulhaq M, Mudigdo A, Utomo P, Wasita B, Warman FI. Platelet-rich fibrin as a tissue engineering material in accelerate bone healing in rat bone defects: A systematic review and meta-analysis. Ann Med Surg (Lond). 2022; 84:104869.
Bolükbas N, Yeniyol S, Tekkesin MS, Altunatmaz K. The use of platelet-rich fibrin in combination with biphasic calcium phosphate in the treatment of bone defects: a histologic and histomorphometric study. Curr Ther Res Clin Exp. 2013; 75:15–21.
Singh A, Kohli M, Gupta N. Platelet rich fibrin: a novel approach for osseous regeneration. J Maxillofac Oral Surg. 2012; 11(4):430–434.
Shetye AG, Rathee M, Jain P, Agarkar V, Kaushik S, Alam M. Effect of advanced platelet-rich fibrin and concentrated growth factor on tissues around implants in maxillary anterior region. J Indian Prosthodont Soc. 2022; 22(2):169-178.
Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR,Strauss JE, Georgeff KR. Platelet-rich plasma: growth factorenhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 85(6):638-646.
Whitman DH, Berry RL, Green DM. Platelet gel: an autologousalternative to fibrin glue with applications in oral and maxillo-facial surgery. J Oral Maxillofac Surg. 1997; 55(11):1294-1299.
Menchisheva Y, Mirzakulova U, Yui R. Use of platelet-rich plasmato facilitate wound healing.Int Wound J. 2019; 16(2):343-353.
Kim SA, Ryu HW, Lee KS, et al. Application of platelet-richplasma accelerates the wound healing process in acute andchronic ulcers through rapid migration and upregulation of cyclinA and CDK4 in HaCaT cells. Mol Med Rep. 2013; 7(2):476-480.
Soliman AF, Saif-Elnasr M, Abdel FS. Platelet-rich plasma ame-liorates gamma radiation-induced nephrotoxicity via modulatingoxidative stress and apoptosis. Life Sci. 2019; 219:238-247.
Lai H, Chen G, Zhang W, Wu G, Xia Z. Research trends on platelet-rich plasma in the treatment of wounds during 2002-2021: A 20-year bibliometric analysis. Int Wound J. 2023; 20(6):1882-1892.
Zhou J, Xie Y, Wang WJ, et al. Hand rejuvenation by targeted volume restoration of the dorsal fat compartments. Aesthet Surg J. 2017; 38(1):92–100.
Riyaz FR, Ozog D. Hand rejuvenation. Semin Cutan Med Surg. 2015; 34(3):147–52.
Butterwick K, Sadick N. Hand rejuvenation using a combination approach. Dermatol Surg. 2016; 42 Suppl 2:S108–18.
Figueredo VO, Miot HA, Soares Dias J, Nunes GJB, Barros de Souza M, Bagatin E. Efficacy and Safety of 2 Injection Techniques for Hand Biostimulatory Treatment With Diluted Calcium Hydroxylapatite. Dermatol Surg. 2020; 46 Suppl 1:S54-S61.
Corduff N, Chen JF, Chen YH, Choi HS, Goldie K, Lam Y, Lesthari NI, Lim TS, Luo S, Quiambao A, Siew TW, Tseng FW, Chao YYY. Pan-Asian Consensus on Calcium Hydroxyapatite for Skin Biostimulation, Contouring, and Combination Treatments. J Clin Aesthet Dermatol. 2021; 14(8):E76-E85.
Klein AW, Elson ML. The history of substances for soft tissue augmentation. Dermatol Surg. 2006; 26(12):1096–195.
Murray CA, Zloty D, Warshawski L. The evolution of soft tissue fillers in clinical practice. Dematol Clin. 2005; 23(2):343–63.
Tzikas TL. Evaluation of the Radiance FN soft tissue filler for facial soft tissue augmentation. Arch Facial Plast Surg. 2004; 6(4):234–39.
FDA Radiesse Aprovale, https://www.fda.gov/medical-devices/pma-approvals/radiesse-lidocaine-injectable-implant-p050052s129
Loghem JV, Yutskovskaya YA, Philip Werschler W. Calcium hydroxyapatite: over a decade of clinical experience. J Clin Aesthet Dermatol. 2015; 8(1):38–49.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Andreina Martinez Amado, Julián Hernández, Natalia Ruiz Polania
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
